{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:49:06Z","timestamp":1790808546542,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":1163,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1002\/rth2.12226","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:18:56Z","timestamp":1560125936000},"page":"589-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hemostatic complications associated with ventricular assist devices"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-4128","authenticated-orcid":false,"given":"Talal","family":"Hilal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-4700","authenticated-orcid":false,"given":"Thomas G.","family":"DeLoughery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12226_bb0010","first-page":"e29","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1002\/rth2.12226_bb0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community\u2010based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/rth2.12226_bb0020","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long\u2010term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More \u201cmalignant\u201d than cancer? Five\u2010year survival following a first admission for heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1002\/rth2.12226_bb0030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.healun.2014.08.003","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty\u2010first official adult heart transplant report\u20132014; focus theme: retransplantation","volume":"33","author":"Lund","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0035","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/asheducation-2017.1.674","article-title":"Anticoagulation with VADs and ECMO: walking the tightrope","volume":"2017","author":"Raffini","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1002\/rth2.12226_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0003-4975(99)00042-9","article-title":"The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure","volume":"67","author":"Rose","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0050","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous\u2010flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous\u2010flow device in patients awaiting heart transplantation","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1313385","article-title":"Unexpected abrupt increase in left ventricular assist device thrombosis","volume":"370","author":"Starling","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0065","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/CIRCULATIONAHA.111.058412","article-title":"Use of an intrapericardial, continuous\u2010flow, centrifugal pump in patients awaiting heart transplantation","volume":"125","author":"Aaronson","year":"2012","journal-title":"Circulation"},{"key":"10.1002\/rth2.12226_bb0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajh.23836","article-title":"Anticoagulation management of left ventricular assist devices","volume":"90","author":"Connors","year":"2015","journal-title":"Am J Hematol"},{"issue":"suppl 1","key":"10.1002\/rth2.12226_bb0085","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1111\/jth.12963","article-title":"Extracorporeal life support: the precarious balance of hemostasis","volume":"13","author":"Annich","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"suppl 2","key":"10.1002\/rth2.12226_bb0090","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.thromres.2012.02.039","article-title":"Regulatory mechanisms of the plasma contact system","volume":"129","author":"Maas","year":"2012","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12226_bb0095","doi-asserted-by":"crossref","first-page":"M790","DOI":"10.1097\/00002480-199507000-00122","article-title":"Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device","volume":"41","author":"Himmelreich","year":"1995","journal-title":"ASAIO J"},{"key":"10.1002\/rth2.12226_bb0100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/(SICI)1097-4636(20000315)49:4<460::AID-JBM4>3.0.CO;2-3","article-title":"Assessing acute platelet adhesion on opaque metallic and polymeric biomaterials with fiber optic microscopy","volume":"49","author":"Schaub","year":"2000","journal-title":"J Biomed Mater Res"},{"key":"10.1002\/rth2.12226_bb0105","doi-asserted-by":"crossref","first-page":"081002","DOI":"10.1115\/1.4007092","article-title":"A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index","volume":"134","author":"Fraser","year":"2012","journal-title":"J Biomech Eng"},{"key":"10.1002\/rth2.12226_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MAT.0b013e318283815c","article-title":"Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous\u2010flow ventricular assist device: in vitro findings","volume":"59","author":"Dassanayaka","year":"2013","journal-title":"ASAIO J"},{"key":"10.1002\/rth2.12226_bb0115","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jvs.2014.12.050","article-title":"Role of high shear rate in thrombosis","volume":"61","author":"Casa","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1002\/rth2.12226_bb0120","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/MAT.0000000000000759","article-title":"Clinical relevance of histopathologic analysis of HeartMate II thrombi","volume":"64","author":"Baumann Kreuziger","year":"2018","journal-title":"ASAIO J"},{"key":"10.1002\/rth2.12226_bb0125","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2009.02.048","article-title":"Severely impaired von Willebrand factor\u2013dependent platelet aggregation in patients with a continuous\u2010flow left ventricular assist device (HeartMate II)","volume":"53","author":"Klovaite","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/rth2.12226_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.healun.2013.08.021","article-title":"Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant","volume":"33","author":"Cowger","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchf.2013.10.008","article-title":"Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device","volume":"2","author":"Meyer","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1002\/rth2.12226_bb0140","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.athoracsur.2010.04.099","article-title":"Acquired von Willebrand syndrome in continuous\u2010flow ventricular assist device recipients","volume":"90","author":"Crow","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.healun.2013.11.010","article-title":"Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices","volume":"33","author":"Birschmann","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0150","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"key":"10.1002\/rth2.12226_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtcvs.2014.09.031","article-title":"Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage","volume":"149","author":"Bartoli","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/rth2.12226_bb0160","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1160\/TH09-07-0497","article-title":"Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart","volume":"103","author":"Heilmann","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12226_bb0165","first-page":"1328","article-title":"Acquired Von Willebrand syndrome is an early\u2010onset problem in ventricular assist device patients","volume":"40","author":"Heilmann","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1002\/rth2.12226_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006519","article-title":"Platelet secretion defects and acquired von Willebrand syndrome in patients with ventricular assist devices","volume":"7","author":"Geisen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1002\/rth2.12226_bb0175","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0180","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous\u2010flow mechanical device support contributes to a high prevalence of bleeding during long\u2010term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/rth2.12226_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MAT.0000000000000290","article-title":"Incidence of hemolysis in patients with cardiogenic shock treated with impella percutaneous left ventricular assist device","volume":"62","author":"Badiye","year":"2016","journal-title":"ASAIO J"},{"key":"10.1002\/rth2.12226_bb0190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejcts.2009.04.015","article-title":"Haemolysis in patients with ventricular assist devices: major differences between systems","volume":"36","author":"Heilmann","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1002\/rth2.12226_bb0195","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/rth2.12226_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V57.1.83.83","article-title":"The kidneys in paroxysmal nocturnal hemoglobinuria","volume":"57","author":"Clark","year":"1981","journal-title":"Blood"},{"key":"10.1002\/rth2.12226_bb0205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1476-5381.1987.tb11367.x","article-title":"The anti\u2010aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide","volume":"92","author":"Radomski","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1002\/rth2.12226_bb0210","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000126837.88743.DD","article-title":"Rapid regulation of platelet activation in vivo by nitric oxide","volume":"109","author":"Schafer","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/rth2.12226_bb0215","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/0016-5085(95)90584-7","article-title":"The effects of recombinant human hemoglobin on esophageal motor functions in humans","volume":"109","author":"Murray","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/rth2.12226_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002896","article-title":"Watchful waiting in continuous\u2010flow left ventricular assist device patients with ongoing hemolysis is associated with an increased risk for cerebrovascular accident or death","volume":"9","author":"Levin","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1002\/rth2.12226_bb0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/eurjhf\/hfs012","article-title":"Continuous\u2010flow left ventricular assist device support in patients with advanced heart failure: points of interest for the daily management","volume":"14","author":"Felix","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1002\/rth2.12226_bb0230","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jth.12948","article-title":"Antithrombotic therapy for left ventricular assist devices in adults: a systematic review","volume":"13","author":"Baumann Kreuziger","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12226_bb0235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/ejcts\/ezs320","article-title":"Cerebrovascular complications of left ventricular assist devices","volume":"42","author":"Backes","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1002\/rth2.12226_bb0240","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.biomaterials.2008.12.041","article-title":"Contact activation of blood\u2010plasma coagulation","volume":"30","author":"Vogler","year":"2009","journal-title":"Biomaterials"},{"key":"10.1002\/rth2.12226_bb0245","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.athoracsur.2015.02.094","article-title":"Stroke after left ventricular assist device implantation: outcomes in the continuous\u2010flow era","volume":"100","author":"Harvey","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0250","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.healun.2009.05.018","article-title":"Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti\u2010coagulation","volume":"28","author":"Boyle","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0255","doi-asserted-by":"crossref","first-page":"e002680","DOI":"10.1161\/CIRCHEARTFAILURE.115.002680","article-title":"Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous\u2010flow left ventricular assist devices","volume":"9","author":"Nassif","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1002\/rth2.12226_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2013.12.002","article-title":"The vexing problem of thrombosis in long\u2010term mechanical circulatory support","volume":"33","author":"Mehra","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40256-014-0102-3","article-title":"Management of pump thrombosis in patients with left ventricular assist devices","volume":"15","author":"Stulak","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1002\/rth2.12226_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healun.2013.10.005","article-title":"Device thrombosis in HeartMate II continuous\u2010flow left ventricular assist devices: a multifactorial phenomenon","volume":"33","author":"Uriel","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jocs.12238","article-title":"Diagnosis, nonsurgical management, and prevention of LVAD thrombosis","volume":"29","author":"Bartoli","year":"2014","journal-title":"J Card Surg"},{"key":"10.1002\/rth2.12226_bb0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.healun.2013.08.019","article-title":"Hemolysis in left ventricular assist device: a retrospective analysis of outcomes","volume":"33","author":"Ravichandran","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.healun.2013.11.001","article-title":"Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device","volume":"33","author":"Kirklin","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0290","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtcvs.2006.01.048","article-title":"Heparin\u2010induced thrombocytopenia in patients receiving mechanical circulatory support","volume":"131","author":"Schenk","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/rth2.12226_bb0295","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.athoracsur.2006.05.077","article-title":"Impact of heparin\u2010induced thrombocytopenia on outcome in patients with ventricular assist device support: single\u2010institution experience in 358 consecutive patients","volume":"83","author":"Koster","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0300","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.athoracsur.2008.10.060","article-title":"Heparin\u2010induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?","volume":"87","author":"Warkentin","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0305","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/mtc.2001.111655","article-title":"Heparin antibodies and thromboembolism in heparin\u2010coated and noncoated ventricular assist devices","volume":"121","author":"Koster","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/rth2.12226_bb0310","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin\u2010induced thrombocytopenia: a systematic review and meta\u2010analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"key":"10.1002\/rth2.12226_bb0315","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1213\/ANE.0b013e3182297031","article-title":"A diagnosis of heparin\u2010induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients","volume":"113","author":"Demma","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1002\/rth2.12226_bb0320","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1749-8090-9-55","article-title":"A retrospective evaluation of fondaparinux for confirmed or suspected heparin\u2010induced thrombocytopenia in left\u2010ventricular\u2010assist device patients","volume":"9","author":"Benken","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"10.1002\/rth2.12226_bb0325","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/aor.12168","article-title":"Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices","volume":"38","author":"Pieri","year":"2014","journal-title":"Artif Organs"},{"key":"10.1002\/rth2.12226_bb0330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11239-014-1162-6","article-title":"Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices","volume":"39","author":"Baumann Kreuziger","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"10.1002\/rth2.12226_bb0335","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCHEARTFAILURE.111.962613","article-title":"Mechanisms of bleeding and approach to patients with axial\u2010flow left ventricular assist devices","volume":"4","author":"Suarez","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1002\/rth2.12226_bb0340","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0003-4975(03)00478-8","article-title":"Left ventricular assist devices and bleeding: adding insult to injury","volume":"75","author":"Goldstein","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0345","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.jvca.2014.07.002","article-title":"Risk factors related to transfusion requirements in patients undergoing implantation of ventricular assist devices","volume":"29","author":"Neill","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1002\/rth2.12226_bb0350","first-page":"15","article-title":"Complications of continuous\u2010flow mechanical circulatory support devices","volume":"9","author":"Patel","year":"2015","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1002\/rth2.12226_bb0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/aor.12209","article-title":"Incidence and outcome of pediatric patients with intracranial hemorrhage while supported on ventricular assist devices","volume":"38","author":"Niebler","year":"2014","journal-title":"Artif Organs"},{"key":"10.1002\/rth2.12226_bb0360","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/HCO.0b013e328345af65","article-title":"The next decade in mechanical assist: advances that will help the patient and the doctor","volume":"26","author":"Atluri","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1002\/rth2.12226_bb0365","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MAT.0b013e3182a4b434","article-title":"Gastrointestinal bleeding in patients with ventricular assist devices is highest immediately after implantation","volume":"59","author":"French","year":"2013","journal-title":"ASAIO J"},{"key":"10.1002\/rth2.12226_bb0370","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.healun.2013.07.020","article-title":"Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device","volume":"33","author":"Stulak","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0375","first-page":"475","article-title":"Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention","volume":"3","author":"Harvey","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1002\/rth2.12226_bb0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14797\/mdcj-11-1-24","article-title":"Gastrointestinal bleeding after continuous\u2010flow left ventricular device implantation: review of pathophysiology and management","volume":"11","author":"Guha","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1002\/rth2.12226_bb0385","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.healun.2011.03.008","article-title":"Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device","volume":"30","author":"Demirozu","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0390","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMcibr1205363","article-title":"From clinical observation to mechanism \u2013 Heyde's syndrome","volume":"367","author":"Loscalzo","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12226_bb0395","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1002\/rth2.12226_bb0400","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1538-7836.2006.01815.x","article-title":"Urgent reversal of warfarin with prothrombin complex concentrate","volume":"4","author":"Lankiewicz","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12226_bb0405","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.healun.2015.06.018","article-title":"Safety of reduced anti\u2010thrombotic strategies in HeartMate II patients: a one\u2010year analysis of the US\u2010TRACE Study","volume":"34","author":"Katz","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0410","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.athoracsur.2012.02.035","article-title":"Incidence and management of gastrointestinal bleeding with continuous flow assist devices","volume":"93","author":"Aggarwal","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0415","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1525-1594.2010.01084.x","article-title":"Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single\u2010center experience","volume":"34","author":"Hayes","year":"2010","journal-title":"Artif Organs"},{"key":"10.1002\/rth2.12226_bb0420","doi-asserted-by":"crossref","first-page":"e005082","DOI":"10.1161\/CIRCHEARTFAILURE.118.005082","article-title":"Omega\u20103 therapy is associated with reduced gastrointestinal bleeding in patients with continuous\u2010flow left ventricular assist device","volume":"11","author":"Imamura","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1002\/rth2.12226_bb0425","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/HCO.0000000000000143","article-title":"Anticoagulation strategies for left ventricular assist devices","volume":"30","author":"Toeg","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"10.1002\/rth2.12226_bb0430","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.healun.2010.02.003","article-title":"Post\u2010operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long\u2010term warfarin therapy","volume":"29","author":"Slaughter","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0435","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0440","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2146\/ajhp140538","article-title":"Medication management for left ventricular assist device thrombosis","volume":"72","author":"Hohner","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"10.1002\/rth2.12226_bb0445","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ejcts\/ezt228","article-title":"Is anti\u2010platelet therapy needed in continuous flow left ventricular assist device patients? A single\u2010centre experience","volume":"45","author":"Litzler","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1002\/rth2.12226_bb0450","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.athoracsur.2011.06.081","article-title":"Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices","volume":"92","author":"John","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/rth2.12226_bb0455","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MAT.0000000000000244","article-title":"Developing an anti\u2010Xa\u2010based anticoagulation protocol for patients with percutaneous ventricular assist devices","volume":"61","author":"Sieg","year":"2015","journal-title":"ASAIO J"},{"key":"10.1002\/rth2.12226_bb0460","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archinte.158.10.1140","article-title":"Effect of warfarin on activated partial thromboplastin time in patients receiving heparin","volume":"158","author":"Kearon","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1002\/rth2.12226_bb0465","first-page":"20","article-title":"Dabigatran etexilate as second\u2010line therapy in patients with a left ventricular assist device","volume":"56","author":"Terrovitis","year":"2015","journal-title":"Hellenic J Cardiol"},{"key":"10.1002\/rth2.12226_bb0470","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1002\/rth2.12226_bb0475","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.healun.2013.11.002","article-title":"The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices","volume":"33","author":"Tellor","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0480","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jtcvs.2010.11.022","article-title":"Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics","volume":"142","author":"Kiernan","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/rth2.12226_bb0485","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1053\/j.jvca.2010.09.005","article-title":"Case 6\u20102010: noncardiac surgery in patients with a left ventricular assist device","volume":"24","author":"Ficke","year":"2010","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1002\/rth2.12226_bb0490","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.healun.2012.02.023","article-title":"Non\u2010cardiac surgery in patients on long\u2010term left ventricular assist device support","volume":"31","author":"Morgan","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/rth2.12226_bb0495","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.mayocp.2013.03.019","article-title":"The perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery","volume":"88","author":"Barbara","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1002\/rth2.12226_bb0500","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/000313480607200213","article-title":"Management of general surgical problems in patients with left ventricular assist devices","volume":"72","author":"Eckhauser","year":"2006","journal-title":"Am Surg"},{"key":"10.1002\/rth2.12226_bb0505","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.amjsurg.2008.05.009","article-title":"Noncardiac surgical procedures in patient supported with long\u2010term implantable left ventricular assist device","volume":"197","author":"Garatti","year":"2009","journal-title":"Am J Surg"},{"key":"10.1002\/rth2.12226_bb0510","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12871-015-0157-y","article-title":"Ventricular assist devices and non\u2010cardiac surgery","volume":"15","author":"Roberts","year":"2015","journal-title":"BMC Anesthesiol."}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12226","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12226","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12226","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922017861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922017861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:18:48Z","timestamp":1762863528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922017861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2475037922017861"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12226","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostatic complications associated with ventricular assist devices","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}